1. Home
  2. MBINM vs BRTX Comparison

MBINM vs BRTX Comparison

Compare MBINM & BRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBINM
  • BRTX
  • Stock Information
  • Founded
  • MBINM N/A
  • BRTX 1997
  • Country
  • MBINM United States
  • BRTX United States
  • Employees
  • MBINM 663
  • BRTX N/A
  • Industry
  • MBINM Major Banks
  • BRTX Managed Health Care
  • Sector
  • MBINM Finance
  • BRTX Health Care
  • Exchange
  • MBINM Nasdaq
  • BRTX Nasdaq
  • Market Cap
  • MBINM N/A
  • BRTX 12.6M
  • IPO Year
  • MBINM N/A
  • BRTX N/A
  • Fundamental
  • Price
  • MBINM $25.03
  • BRTX $1.60
  • Analyst Decision
  • MBINM
  • BRTX Strong Buy
  • Analyst Count
  • MBINM 0
  • BRTX 1
  • Target Price
  • MBINM N/A
  • BRTX $18.00
  • AVG Volume (30 Days)
  • MBINM N/A
  • BRTX 151.8K
  • Earning Date
  • MBINM N/A
  • BRTX 08-12-2025
  • Dividend Yield
  • MBINM N/A
  • BRTX N/A
  • EPS Growth
  • MBINM N/A
  • BRTX N/A
  • EPS
  • MBINM N/A
  • BRTX N/A
  • Revenue
  • MBINM N/A
  • BRTX $391,000.00
  • Revenue This Year
  • MBINM N/A
  • BRTX $391.52
  • Revenue Next Year
  • MBINM N/A
  • BRTX $3.50
  • P/E Ratio
  • MBINM N/A
  • BRTX N/A
  • Revenue Growth
  • MBINM N/A
  • BRTX 161.54
  • 52 Week Low
  • MBINM N/A
  • BRTX $1.21
  • 52 Week High
  • MBINM N/A
  • BRTX $2.55
  • Technical
  • Relative Strength Index (RSI)
  • MBINM 48.98
  • BRTX 45.93
  • Support Level
  • MBINM $24.81
  • BRTX $1.51
  • Resistance Level
  • MBINM $25.18
  • BRTX $1.79
  • Average True Range (ATR)
  • MBINM 0.15
  • BRTX 0.10
  • MACD
  • MBINM 0.01
  • BRTX -0.00
  • Stochastic Oscillator
  • MBINM 60.53
  • BRTX 32.14

About MBINM Merchants Bancorp

Merchants Bancorp is a United States based bank holding company. It operates multiple lines of business focusing on FHA (Federal Housing Administration) multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, and traditional community banking. The business segments of the company are: Multi-family Mortgage Banking which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing segment which funds agency-eligible residential loans as well as commercial loans to nondepository financial institutions; and the Banking segment, which generates maximum revenue, and provides various financial products and services to consumers and businesses.

About BRTX BioRestorative Therapies Inc. (NV)

BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.

Share on Social Networks: